New Delhi, Aug. 12 -- The Supreme Court on Monday ended further monitoring of its directions on misleading advertisements observing that the matter needs to be regulated by the Centre and not by courts. Closing proceedings in a petition filed in 2022 by Indian Medical Association (IMA) against Patanjali over misleading advertisements, a bench of justices BV Nagarathna and KV Viswanathan observed that there was no "object and purpose" in continuing with these proceedings as the relief sought by IMA had been achieved. IMA claimed that Patanjali's advertisements were in violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 which prohibits advertisements promising cure of a range of illnesses such as blood pressure,...